Finance

Lists
CAMX:STO
Camurus AB
739,00 SEK
-0,14%
(-1,00) 1D
20-ноя., 13:35:02 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CAMX...
Open
738,50 SEK
High
745,50 SEK
Low
733,50 SEK
Mkt. cap
44,36 млд
Avg. vol.
103,71 миң
Volume
29,44 миң
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 млн
No. of employees
323
Open
738,50 SEK
High
745,50 SEK
Low
733,50 SEK
Mkt. cap
44,36 млд
Avg. vol.
103,71 миң
Volume
29,44 миң
52-wk high
750,00 SEK
52-wk low
430,80 SEK
Shares outstanding
60,56 млн
No. of employees
323
News stories
From web sources and news partners
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap. Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees323
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
464,46 млн
533,10 млн
702,08 млн
724,01 млн
Cost of goods sold
36,38 млн
37,16 млн
44,14 млн
46,35 млн
Cost of revenue
36,38 млн
37,16 млн
44,14 млн
46,35 млн
Research and development expenses
124,94 млн
137,61 млн
125,16 млн
141,92 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
184,49 млн
177,48 млн
232,32 млн
205,10 млн
Operating expense
304,07 млн
327,54 млн
365,44 млн
355,72 млн
Total operating expenses
340,45 млн
364,70 млн
409,58 млн
402,08 млн
Operating income
124,01 млн
168,40 млн
292,50 млн
321,93 млн
Other non operating income
-17,00 миң
-
-
-
EBT including unusual items
126,84 млн
183,86 млн
309,68 млн
340,54 млн
EBT excluding unusual items
126,80 млн
183,86 млн
309,68 млн
340,54 млн
Income tax expense
25,96 млн
40,04 млн
68,85 млн
70,55 млн
Effective tax rate
20,47%
21,78%
22,23%
20,72%
Other operating expenses
-5,36 млн
12,45 млн
7,95 млн
8,71 млн
Net income
100,88 млн
143,82 млн
240,83 млн
269,99 млн
Net profit margin
21,72%
26,98%
34,30%
37,29%
Earnings per share
1,67
2,40
4,05
4,53
Interest and investment income
15,54 млн
16,93 млн
18,60 млн
20,09 млн
Interest expense
-1,46 млн
-1,47 млн
-1,42 млн
-1,47 млн
Net interest expenses
14,08 млн
15,46 млн
17,18 млн
18,62 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
130,67 млн
175,28 млн
299,63 млн
329,12 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору